TY - JOUR
T1 - Continuous surveillance of a pregnancy clinical guideline :
T2 - An early experience
AU - Martínez García, Laura
AU - Pardo-Hernandez, Hector
AU - Sanabria, Andrea Juliana
AU - Alonso-Coello, Pablo
AU - Aceituno-Velasco, Longinos
AU - Araya, Ignacio
AU - Muñoz, Emilia Bailon
AU - Díaz del Campo, Petra
AU - Etxeandia-Ikobaltzeta, Itziar
AU - Fillol Crespo, Manuel
AU - Fuertes Luis, Lucía
AU - García Álvarez, Elvira
AU - García Carrascosa, Laura
AU - Gómez Gómez, Natalia
AU - Herrera Crerizo, Blanca
AU - Landa Goñi, Jacinta
AU - López, Dario
AU - Louro González, Arturo
AU - Martínez-Romero, María Dolores
AU - Martín-López, Juliana Ester
AU - Montejo Ráez, Adoración
AU - Osorio, Dimelza
AU - Roman Romera, Isabel
AU - Salcedo-Fernandez, Flavia
AU - Selva, A
AU - Solà, Ivan
AU - Strivens, Helen
AU - Torrejón Cardoso, Rafael
AU - Trujillo Martín, Mar
AU - Vernooij, Robin W. M
PY - 2017
Y1 - 2017
N2 - To date there is no consensus about the optimal strategy for keeping clinical guidelines (CGs) up-to-date. The aims of this study were (1) to develop a continuous surveillance and updating strategy for CGs and (2) to test the strategy in a specific CG. The main steps were as follows: (1) recruiting members for the CG Updating Working Group, (2) mapping the CG, (3) identifying new evidence from the CG Updating Working Group, (4) designing and running restricted literature searches, (5) reviewing drugs and medical devices alerts, (6) screening and assessing the new evidence, (7) reviewing and, if necessary, modifying clinical questions and recommendations, and (8) updating the CG document. The Pregnancy CG Updating Working Group consisted of 29 members, including clinicians, patients and caregivers, and clinical guideline methodology experts. We selected 69 clinical questions (123 recommendations) from the "Assistance during pregnancy" section. For the first update cycle (32-month duration), 9710 references were identified. Of these, 318 were pertinent, 289 were relevant, and 55 were classified as potential key references. For the second and third update cycles (6-month duration each), 2160 and 2010 references were retrieved, respectively. The continuous surveillance and updating strategy has not yet been completely implemented. Further resources are needed in updating the CG field, both for implementing updating strategies and for developing methodological research.
AB - To date there is no consensus about the optimal strategy for keeping clinical guidelines (CGs) up-to-date. The aims of this study were (1) to develop a continuous surveillance and updating strategy for CGs and (2) to test the strategy in a specific CG. The main steps were as follows: (1) recruiting members for the CG Updating Working Group, (2) mapping the CG, (3) identifying new evidence from the CG Updating Working Group, (4) designing and running restricted literature searches, (5) reviewing drugs and medical devices alerts, (6) screening and assessing the new evidence, (7) reviewing and, if necessary, modifying clinical questions and recommendations, and (8) updating the CG document. The Pregnancy CG Updating Working Group consisted of 29 members, including clinicians, patients and caregivers, and clinical guideline methodology experts. We selected 69 clinical questions (123 recommendations) from the "Assistance during pregnancy" section. For the first update cycle (32-month duration), 9710 references were identified. Of these, 318 were pertinent, 289 were relevant, and 55 were classified as potential key references. For the second and third update cycles (6-month duration each), 2160 and 2010 references were retrieved, respectively. The continuous surveillance and updating strategy has not yet been completely implemented. Further resources are needed in updating the CG field, both for implementing updating strategies and for developing methodological research.
KW - Diffusion of innovation
KW - Dissemination and implementation
KW - Evidence-based medicine
KW - Methodology
KW - Practice guidelines
KW - Updating
U2 - 10.1186/s13643-017-0506-7
DO - 10.1186/s13643-017-0506-7
M3 - Article
C2 - 28705226
SN - 2046-4053
VL - 6
JO - Systematic Reviews
JF - Systematic Reviews
IS - 1
ER -